# EDGAR Filing Document

**Accession Number:** 0001718500
**File Stem:** 0001520138-25-000338
**Filing Date:** 2025-11
**Character Count:** 7322
**Document Hash:** 006f8da6ccf9dc9161dbff911285a47c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001520138-25-000338.hdr.sgml**: 20251103

**ACCESSION NUMBER**: 0001520138-25-000338

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251103

**FILED AS OF DATE**: 20251103

**DATE AS OF CHANGE**: 20251103

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Brown Jeffrey B.
- **CENTRAL INDEX KEY:** 0001945871

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41958
- **FILM NUMBER:** 251445142

**MAIL ADDRESS:**
- **STREET 1:** C/O REVIV3 PROCARE COMPANY
- **STREET 2:** 9480 TELSTAR AVE., SUITE 5
- **CITY:** EL MONTE
- **STATE:** CA
- **ZIP:** 91731
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Axil Brands, Inc.
- **CENTRAL INDEX KEY:** 0001718500
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 474125218
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0531

**BUSINESS ADDRESS:**
- **STREET 1:** 9150 WILSHIRE BOULEVARD
- **STREET 2:** UNIT 245
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212
- **BUSINESS PHONE:** 888-638-8883

**MAIL ADDRESS:**
- **STREET 1:** 9150 WILSHIRE BOULEVARD
- **STREET 2:** UNIT 245
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Reviv3 Procare Co
- **DATE OF NAME CHANGE:** 20171003

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Brown Jeffrey B.<br><sub>(Last) (First) (Middle)</sub><br>C/O AXIL BRANDS, INC.<br>9150 WILSHIRE BOULEVARD, UNIT 245<br><sub>(Street)</sub><br>BEVERLY HILLS, CA 90212<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-03 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CFO, COO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Axil Brands, Inc. [ AXIL ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-11-03 |  | C |  | 45000 | A | <sup>(1)(5)</sup> | 145000 | I | By BZ Capital Strategies<sup>(4)</sup> |
| Common Stock |  |  |  |  |  |  |  | 15143 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Series A Preferred Stock | <sup>(1)</sup> | 2025-11-03 |  | C<sup>(5)</sup> |  |  | 900000 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 45000<sup>(1)</sup> | <sup>(1)(5)</sup> | 300000 | I | By BZ Capital Strategies<sup>(4)</sup> |
| Stock Option (right to buy) | $1.80 |  |  |  |  |  |  | <sup>(2)</sup> | 2032-04-20 | Common Stock | 110000 |  | 110000 | D |  |
| Stock Option (right to buy) | $4.01 |  |  |  |  |  |  | <sup>(3)</sup> | 2034-10-14 | Common Stock | 250000 |  | 250000 | D |  |

---

### Footnotes:

(1) The Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), is convertible into shares of the Issuer's common stock on a twenty-for-one basis, at the option of the holder, at any time; provided, that the holder may not convert that number of shares of Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Issuer's common stock, as determined in accordance with Sections 13(d) and (g) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder. The Preferred Stock has no expiration date.

(2) Fully exercisable.

(3) Options vest in 48 equal monthly installments, beginning on October 31, 2024, subject to continued employment through the vesting date.

(4) Jeffrey Brown is the co-owner, Chairman of the board of directors and Chief Financial Officer of BZ Capital Strategies.

(5) On November 3, 2025, BZ Capital Strategies converted 900,000 shares of Preferred Stock into 45,000 shares of the Issuer's common stock.

**Signature:** /s/ Jeffrey B. Brown  
**Date:** 2025-11-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**